On the intermediary mechanism in micro-factors between Chinese medicine constitutions and ovarian cancer

HAN Feng-juan; SHEN Ying

您当前的位置：

首页 >

文章列表页 >

On the intermediary mechanism in micro-factors between Chinese medicine constitutions and ovarian cancer

更新时间：2022-08-31

- On the intermediary mechanism in micro-factors between Chinese medicine constitutions and ovarian cancer
- Shanghai Journal of Traditional Chinese Medicine Vol. 49, Issue 12, Pages: 8-10(2015)
- 作者机构：
  
  1. 黑龙江中医药大学附属第一医院妇科,黑龙江,哈尔滨,150040
  2. 黑龙江中医药大学2013级中医临床硕士研究生班,黑龙江,哈尔滨,150040
- 作者简介：
- 基金信息：
- DOI：
  CLC：
扫描看全文
HAN Feng-juan, SHEN Ying. On the intermediary mechanism in micro-factors between Chinese medicine constitutions and ovarian cancer. [J]. Shanghai Journal of Traditional Chinese Medicine 49(12):8-10(2015)
DOI：

HAN Feng-juan, SHEN Ying. On the intermediary mechanism in micro-factors between Chinese medicine constitutions and ovarian cancer. [J]. Shanghai Journal of Traditional Chinese Medicine 49(12):8-10(2015) DOI：

摘要

根据中医体质与卵巢癌的已有研究成果进行推导,构建中医体质与卵巢癌发病的微观因子中介机制模型,以助揭示其中可能存在的作用路径集,从而为中医体质与卵巢癌的关系研究提供新的思路。

Abstract

Based on the existing research literatures on the ovarian cancer and its relationship with Chinese medicine constitutions,an intermediary mechanism model was built to describe how Chinese medicine constitutions affect on ovarian cancer through the micro factors. The possible affection path sets can be researched with this model,which helps to provide new analysis perspective on studying the relationship between Chinese medicine constitutions and ovarian cancer.

关键词

中医体质卵巢癌微观因子中介机制

Keywords

Chinese medicine constitutionovarian cancermicro factorsintermediary mechanism

references

Views

376

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress on epithelial⁃mesenchymal transition in drug resistance of ovarian cancer and intervention of traditional Chinese medicine

Effect of Buyi Xiaozheng Prescription on immune microenvironment in window period of chemotherapy for advanced ovarian cancer

An experimental study on inhibitory effect of tetrandrine on regulating expression of miR-21 on epithelial-mesenchymal transition in ovarian cancer

Investigation of Tian Jianhui’s TCM medication regularity for gynecological cancers based on data mining

New exploration on ovarian cancer diagnasis and treatment with integrated Chinese and western medicine in a multiple disciplinary team

Related Author

No data

Related Institution

Institute of Interdisciplinary Integrative Medicine Research， Shanghai University of Traditional Chinese Medicine

Renji Hospital， Shanghai Jiaotong University School of Medicine

Department of Gynecology, Zhengzhou Yihe Hospital Affiliated to Henan University

Department of Obstetrics and Gynecology, the First Affiliated Hospital of Zhengzhou University

Department of Obstetrics and Gynecology, People’s Hospital of Henan University of Traditional Chinese Medicine

⁰